Brief: Theradiag H1 Operating Loss Narrows To EUR 0.1 Million

Theradiag SA

19/09/2022 06:43

Sept 19 (Reuters) - Theradiag SA  ALTHE.PA :
    * THERADIAG ANNOUNCES ITS RESULTS FOR THE FIRST HALF OF
2022:
BREAKING-EVEN AND CONFIRMING ITS ABILITY TO BE STRUCTURALLY
PROFITABLE FROM EARLY 2023
    * H1 REVENUE EUR 6.3 MILLION VERSUS EUR 5.5 MILLION YEAR AGO
    * NET CASH POSITION OF EUR 6.0 MILLION ON JUNE 30, 2022,
VERSUS
EUR 7.1 MILLION ON DECEMBER 31, 2021
    * H1 OPERATING LOSS EUR 0.1 MILLION VERSUS LOSS OF EUR 0.2
MILLION
YEAR AGO
    * OVERALL NET RESULT IMPROVED BY 38% TO -EUR 56 THOUSAND AT
JUNE
30, 2022 VERSUS -EUR 92 THOUSAND AT JUNE 30, 2021
    * IS CONTINUING ITS PROGRESS TOWARDS PROFITABILITY, WHICH
SHOULD
BE ACHIEVED BY EARLY 2023 AT LATEST-CEO

Source text for Eikon:  ID:nBw2PtRTka 
Further company coverage:  ALTHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))